Brian J. Druker, M.D.
- Specialty:
- Cancer and Blood Disorders
- Special Interest:
- Chronic Myeloid Leukemia
- Accepting Patients:
- Yes
- Languages:
- English
"There is no question that we can defeat cancer. What it requires is knowledge. When we understand what is broken, we can fix it."
Biography
Dr. Druker specializes in caring for and treating patients with chronic myelogenous leukemia (CML). In his early medical training, witnessing chemotherapy's effects on patients drove him to find a better way to treat cancer. Starting in the lab, he led the development and clinical trials of the drug Gleevec for CML. Gleevec was the first of its kind, highly successful daily oral medication to target damaged cells, leave healthy cells alone and cause minimal side effects. Dr. Druker continues to seek even better treatments for his patients, who are his inspiration. Dr. Druker's favorite way to spend his free time is with his wife, son and two daughters. With his busy schedule, he runs to and from work, rain or shine, to ensure he stays healthy. In 2009, Dr. Druker was honored with "America's Nobel Prize", the Lasker-DeBakey Award for Clinical Medical Research.
Clinical Position
Director, OHSU Knight Cancer Institute
Education
- Degree:
M.D., University of California San Diego, 1981
-
Residency:
Barnes Hospital, Washington University, St. Louis -
Fellowship:
Medical Oncology - Dana-Farber Cancer Institute, Harvard Medical School, Boston -
Certifications:
American Board of Internal Medicine, 1984
American Board of Internal Medicine, 1987
